Prot #CA-4948-101: An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Relapsed or Refractory Primary Central Nervous Sy

Project: Research project

Project Details

StatusActive
Effective start/end date8/8/248/8/27

Funding

  • Catalyst Clinical Research, LLC (Prot #CA-4948-101 // Prot #CA-4948-101)
  • Curis, Inc. (Prot #CA-4948-101 // Prot #CA-4948-101)